Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Burman

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
JAMA|April 7, 2005
Readability of notice of privacy forms used by major health care institutionsPeter Breese, William Burman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 15, 2005
Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximabRobert Belknap, Randall Reves, William Burman
Journal of Empirical Research on Human Research Ethics : JERHRE|April 24, 2009
Content Among Locally Approved HIPAA Authorization forms for ResearchPeter Breese, Cornelis Rietmeijer, William Burman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 5, 2002
Another step on the path to better TB therapiesAndrew Vernon, William Burman, C Robert Horsburgh
The Lancet. Infectious Diseases|October 31, 2024
Predictable excess hepatotoxicity in the SimpliciTB trialWilliam Burman, C Robert Horsburgh, James Johnston
Annals of Internal Medicine|December 8, 2004
The Health Insurance Portability and Accountability Act and the informed consent processPeter Breese, William Burman, Cornelis Rietmeijer, et al.
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisWilliam Burman, Greg J Fox, C Robert Horsburgh
Obstetrics and Gynecology|July 2, 2004
The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancyPeter Breese, William Burman, Judith Shlay, et al.
Eclinicalmedicine|April 1, 2025
Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic reviewWilliam Burman, Jayne Ellis, Gila Hale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and CanadaLorna Bozeman, William Burman, Beverly Metchock, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
JAMA|April 7, 2005
Readability of notice of privacy forms used by major health care institutionsPeter Breese, William Burman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 15, 2005
Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximabRobert Belknap, Randall Reves, William Burman
Journal of Empirical Research on Human Research Ethics : JERHRE|April 24, 2009
Content Among Locally Approved HIPAA Authorization forms for ResearchPeter Breese, Cornelis Rietmeijer, William Burman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 5, 2002
Another step on the path to better TB therapiesAndrew Vernon, William Burman, C Robert Horsburgh
The Lancet. Infectious Diseases|October 31, 2024
Predictable excess hepatotoxicity in the SimpliciTB trialWilliam Burman, C Robert Horsburgh, James Johnston
Annals of Internal Medicine|December 8, 2004
The Health Insurance Portability and Accountability Act and the informed consent processPeter Breese, William Burman, Cornelis Rietmeijer, et al.
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisWilliam Burman, Greg J Fox, C Robert Horsburgh
Obstetrics and Gynecology|July 2, 2004
The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancyPeter Breese, William Burman, Judith Shlay, et al.
Eclinicalmedicine|April 1, 2025
Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic reviewWilliam Burman, Jayne Ellis, Gila Hale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and CanadaLorna Bozeman, William Burman, Beverly Metchock, et al.
Pageof 4